CN102269765B - Immunochromatographic test paper for detecting enrofloxacin and preparation method thereof - Google Patents
Immunochromatographic test paper for detecting enrofloxacin and preparation method thereof Download PDFInfo
- Publication number
- CN102269765B CN102269765B CN201110157590.5A CN201110157590A CN102269765B CN 102269765 B CN102269765 B CN 102269765B CN 201110157590 A CN201110157590 A CN 201110157590A CN 102269765 B CN102269765 B CN 102269765B
- Authority
- CN
- China
- Prior art keywords
- enrofloxacin
- antibody
- composite particle
- superparamagnetism composite
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention discloses immunochromatographic test paper for detecting enrofloxacin and a preparation method thereof. The immunochromatographic test paper for detecting the enrofloxacin comprises a sample pad containing an enrofloxacin antibody labeled by superparamagnetic composite particles, a nitrocellulose membrane connected at one end of the sample pad and a water-absorbing pad connected at the other end of the nitrocellulose membrane, wherein the nitrocellulose membrane is coated with a detection line and a quality control line, which are separated mutually, the detection line contains an enrofloxacin antigen and the quality control line contains an anti-antibody which can be specifically combined with the enrofloxacin antibody. Experiments prove that, by using the test paper provided by the invention for detecting the enrofloxacin, the sensitivity is high, the specificity is strong, the test is fast and simple, and the objective determination can be realized.
Description
Technical field
The detection reagent that the present invention relates to enrofloxacin residual thing, is specifically related to a kind of immune chromatography test paper that detects Enrofloxacin and preparation method thereof.
Background technology
Enrofloxacin (Enrofloxacin, EF) is a kind of fluoroquinolones FQs medicine of animal specific, for artificial synthetic type broad-spectrum sterilization antibacterials, is widely used in aquatic products and livestock and poultry cultivation, has become one of the at present conventional fishing medicine of China and veterinary drug.The report of drug resistance, residual toxicity and the bad reaction producing while applying about FQs clinical drug is in recent years more and more, and in food, corresponding residual detection also causes people's attention further.China is aquatic products production, consumption and big export country, and Enrofloxacin is that the medicine in recent years aquatic products mainly monitored is one of residual.At present field screening detects with detecting the multiplex Enrofloxacin colloid gold test paper of reagent, but can not finely meet the demands because its sensitivity is low, therefore need develop can be at the scene more accurate and detection method fast.
Sidestream immune chromatography detection technique (LFIAs) based on Ag-Ab immunological response is the emerging technology growing up early 1990s, because of its characteristic fast and easily, is suitable for very much on-the-spot fast monitored.But such technology adopts collaurum as signal labeled molecule more at present, be subject to the restriction of its sensitivity etc., can only be for qualitative detection.
Superparamagnetism composite particle has good magnetism characteristic, because it is subject to background interference little, is particularly suitable for not containing the detection of the biological sample of magnetisable material.When collaurum and fluorescent tag molecule detect for flow measurement immunochromatography, on its film surface, detection zone, observe approximately 10% signaling molecule intensity only, and with the superparamagnetism composite particle material that serves as a mark, the all magnetic signal molecules in the film 3-D solid structure of detection zone can be detected, can greatly improve sensitivity, and the magnetic signal detector of available correspondence reaches quantitative measurement, therefore, superparamagnetism composite particle is the material receiving publicity in LFIAs in recent years.
Yet at present the biological detection of report adopts chemical method first to prepare after the magnetic nano-particle of organic phase as coprecipitation with magnetic nano-composite particle more, then adopts silicon (SiO
2) or the macromolecular material such as polystyrene, polyacrylic acid, gelatin stabilization coating decoration is carried out in its surface, to obtain stable, water miscible magnetic label material.But these prepare often very complicated comparatively of method of modifying, the superparamagnetism composite particle obtaining can not meet the requirement of LFIAs at aspects such as size, biocompatibility, saturated magnetic intensity, external magnetic field response speed, stability and labeling effciencies simultaneously: its size is many between 200～300nm, because magnetic bead particles is bigger than normal, the swimming time on test paper is slower, and developing time is longer; And too little particle cannot provide enough magnetic resonance signals; Also have in addition the problems such as biocompatibility is unstable, the easy polymerization of magnetic bead; These deficiencies have limited the application of superparamagnetism composite particle in LFIAs.
Summary of the invention
An object of the present invention is to provide a kind of immune chromatography test paper that detects Enrofloxacin.
The immune chromatography test paper of detection Enrofloxacin provided by the invention, comprises sample pad, the reacting pad that is connected in described sample pad one end that contains superparamagnetism composite particle mark Enrofloxacin antibody, the adsorptive pads that is connected in the described reacting pad other end; Described reacting pad is coated with detection line and the nature controlling line being separated from each other, and described detection line contains Enrofloxacin antigen, described nature controlling line contain can with the antiantibody of described Enrofloxacin antibody specific bond.
Described reacting pad is nitrocellulose filter;
The condensate that the peptide bond covalent bond that described superparamagnetism composite particle mark Enrofloxacin antibody is Enrofloxacin antibody and superparamagnetism composite particle forms;
Described Enrofloxacin antibody is enrofloxacin monoclonal antibody or Enrofloxacin polyclonal antibody, described Enrofloxacin antibody specific be enrofloxacin monoclonal antibody (Sheng Dilong bio tech ltd, Beijing, ENX-088);
Described Enrofloxacin antigen is the conjugate of Enrofloxacin haptens and carrier protein; When little molecular antigen material and carrier protein couplet, the haptenic average number connecting on each carrier protein molecule be called coupling ratio or in conjunction with than.For reaching the good combination of carrier protein and NC film, can farthest guarantee the extension in site, Enrofloxacin haptens space again simultaneously, it is very important selecting suitable coupling ratio.The size of coupling ratio feeds intake with activity, steric hindrance, the reaction of haptens functional group, and when reaction conditions is relevant.The general mol ratio by adjusting haptens and carrier, reaction environment pH value, temperature, ionic strength etc. are controlled coupling ratio.
Described carrier protein and the haptenic coupling ratio of described Enrofloxacin are 1: 8～1: 10, are suitable for the extension in the coated and site, Enrofloxacin haptens space of antigen, and described carrier protein and the haptenic coupling ratio of described Enrofloxacin are specially 1: 10;
The antiantibody of described and described Enrofloxacin antibody specific bond is sheep anti-mouse igg antibody;
The concentration of described Enrofloxacin antigen and described sheep anti-mouse igg antibody is 1mg/ml.
Described superparamagnetism composite particle mark Enrofloxacin antibody is prepared as follows:
1) by every 2.5mg superparamagnetism composite particle, 0.96mg1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC), 1.15mg N-maloyl imines (NHS) and 1ml concentration, be 0.1M, pH value 2-(N-morpholine) ethyl sulfonic acid (MES) damping fluid that is 4.7 (take 1.066g MES, 0.45g NaCl is dissolved in 50ml pure water, adjust pH to 4.7) mix, reaction, obtains activating rear magnetic particle;
2) by every 2.5mg step 1) to obtain activating rear magnetic particle, 0.15mg Enrofloxacin antibody and 0.8ml concentration be that 50mM pH is that 8.5 borate buffer solution mixes, reacts, and obtains containing the reactant liquor of magnetic particle after coupling;
3) to step 2) add BSA to mix in the reactant liquor that obtains to obtain mixed liquor, reaction, obtain containing the reactant liquor of magnetic particle after sealing;
The concentration of described BSA in described mixed liquor is 5% (quality percentage composition).
Described Enrofloxacin antigen is prepared as follows:
A) get every 35.9ng Enrofloxacin, 3ml DMF (DMF) and 3ml dioxane (dioxane is originally as solution) and be mixed to get mixed liquor a,
B) by the step 1 of every 6ml) the mixed liquor a that obtains and the positive amine of 26.2 μ l tributyls mixes, and obtains mixed liquor b, in mixed liquor b, adds 1.5 μ l isobutyl chlorocarbonates reactions; The Enrofloxacin solution that obtains having activated;
C) get every 100mg carrier protein and be dissolved in 10ml concentration 0.1mol/L, in the dobell's solution that pH is 8.5, obtain carrier protein BAS;
D) the good Enrofloxacin solution of activation every 6ml step B being obtained adds in the described carrier protein BAS that 10ml step C obtains, and reaction, obtains mixed liquor c.
In the preparation method of described superparamagnetism composite particle mark Enrofloxacin antibody:
Step 1) in, temperature of reaction is 37 ℃, and the reaction time is 0.5h;
Step 2) in, temperature of reaction is 25 ℃, and the reaction time is 3.5h;
Step 3) in, temperature of reaction is 37 ℃, and the reaction time is 0.5h.
In the preparation method of described Enrofloxacin antigen:
Steps A) in, described mixing temperature is 25 ℃, and described incorporation time is 30min, and the mode of described mixing is concussion;
Step B) in, the temperature of described mixing is 4 ℃, and the time of described mixing is 15min, and the temperature of described reaction is 25 ℃, and the time of described reaction is 1h;
Step D) in, the temperature of described reaction is 4 ℃, and the reaction time is 12h.
In the preparation method of described superparamagnetism composite particle mark Enrofloxacin antibody:
In described step 3) after, also comprise magnetic particle after the sealing in the described reactant liquor that contains the rear magnetic particle of sealing is washed, suspended, obtain the step of superparamagnetism composite particle mark Enrofloxacin antibody, it is that 0.02mol/L, pH are 7.4 PBS damping fluid that described cleansing solution and suspending liquid are concentration.
In the preparation method of described Enrofloxacin antigen,
At described step D) after also comprise step D) the reactant liquor c that obtains dialysis, freeze-drying, obtain the step of Enrofloxacin antigen.
The dislysate that described dislysate adopts is that concentration is that 0.02mol/L, pH are 7.4 PBS damping fluid, and dialysis time is 48h, and every 6h changes a dislysate.
Described Enrofloxacin haptens is Enrofloxacin;
Described carrier protein is BSA;
Because Enrofloxacin is small-molecule substance, its molecular surface characteristic is unfavorable for reaction zone being the direct combination of NC film, itself and carrier protein need to be carried out could reaching by means of the character of surface of carrier protein after coupling the good combination with NC film.Can be used as the seralbumin that has various animals of carrier protein, as bovine serum albumin(BSA) (Bovine Serum Albumin, BSA), human serum albumins (Human Serum Albumin, HSA), also has keyhole limpet hemocyanin (Keyhole Limpet Hemocyanin, KLH), gamma globulin of thyroglobulin, albumin rabbit serum (RSA), ovalbumin (Ovalbumin, OVA), fibrinogen or rabbit and chicken etc.Research is found, BSA physicochemical property is stable, lysine content is high, free amino group is many, under different pH and ionic strength, all there is larger solubleness, in the situation that containing organic solvent (as pyridine, DMF etc.), all can carry out coupling with haptens, and still keep solvable state after coupling, the splendid selection as carrier protein, therefore the present invention selects BSA as coupling protein.
Described superparamagnetism composite particle is Fe
3o
4nano particle;
Because this superparamagnetism composite particle will the sample pad swimming in above-mentioned reaction plate be realized specific bond and the labeled reactant of Ag-Ab to the test section in the middle of reaction plate, its particle diameter too large (> 300nm) swimming time on test paper is long, and developing time is slow; When coupling, be easier to assemble, and easily produce non-specific responding; The too little magnetic intensity of particle diameter is often inadequate again.
The particle diameter of described superparamagnetism composite particle is 60～300nm, and described particle diameter is specially 80～200nm, and described particle diameter is especially preferably 100nm; The deviation of its particle diameter (CV) between 10～30%, preferably between 10～20%, preferably 15%.
The saturated magnetic intensity of superparamagnetism composite particle and external magnetic field response speed thereof have directly determined the height of detection sensitivity and accuracy thereof, the saturated magnetic intensity of superparamagnetism composite particle prepared by classic method is < 30emu/g all conventionally, and external magnetic field response speed is at 100～200 seconds.
For improving its sensitivity and accuracy, the magnetic saturation intensity of described superparamagnetism composite particle is 30～80emu/g, corresponding external magnetic field response speed is 20～100 seconds, the magnetic saturation intensity of described superparamagnetism composite particle is specially 35～70emu/g, corresponding external magnetic field response speed is 20～50 seconds, the magnetic saturation intensity of described superparamagnetism composite particle is especially preferably 40emu/g, and corresponding external magnetic field response speed is 20 seconds.
For surveying for enrofloxacin residual quality testing, superparamagnetism composite particle surface need be with the group being easy to Enrofloxacin antibody coupling, these groups can be carboxyl, amino groups, the group of optimizing is the surface functional group with carboxyl, conventionally adopt chemical method to connect antibody, with after EDC and NHS activation superparamagnetism composite particle, then close and react and complete coupling reaction with antibody generation carboxylic.By before the condensate forming with peptide bond covalent bond of Enrofloxacin antibody and superparamagnetism composite particle, also comprise that by superparamagnetism composite particle surface functional group be the activation of carboxyl.
The carboxyl-content difference on superparamagnetism composite particle surface can have influence on the sensitivity of detection, for improving sensitivity, described functional group is specially carboxyl, the content of described carboxyl is 50～500 μ mol/g, the content of described carboxyl is specially 50～300 μ mol/g, and the content of described carboxyl is especially preferably 80 μ mol/g.
In immune detection, the performance index of antibody are most important for the accuracy detecting, and typically, high specificity, the antibody that affinity is high, can improve the accuracy of detection significantly.Research is found, is raising sensitivity, and described Enrofloxacin antibody affinity costant is 10
6～10
8m
-1; Described Enrofloxacin antibody affinity costant is specially 10
7～10
8m
-1; Described Enrofloxacin antibody affinity costant is especially preferably 10
8m
-1.
Another object of the present invention is to provide a kind of method of preparing the immune chromatography test paper that detects Enrofloxacin.
Method provided by the invention comprises the steps:
I, prepare sample pad and contain detection line and the reacting pad of nature controlling line respectively;
The reacting pad that contains detection line and nature controlling line and adsorptive pads that II, the sample pad that step I is obtained, step I obtain paste on backboard successively, obtain detecting the immune chromatography test paper of Enrofloxacin;
The described reacting pad that contains detection line and nature controlling line is prepared as follows: the two ends zones of different that described Enrofloxacin antigen and antiantibody described and Enrofloxacin antibody specific bond is sprayed on respectively to reacting pad, form detection line and nature controlling line, obtain the reacting pad that contains detection line and nature controlling line;
Described sample pad is prepared as follows: described superparamagnetism composite particle mark Enrofloxacin antibody is sprayed onto on all-glass paper, obtains sample pad.
In described sample pad preparation method: go forward described superparamagnetism composite particle mark Enrofloxacin antibody is sprayed onto to described all-glass paper, also comprise described in pre-service the step of superparamagnetism composite particle mark Enrofloxacin antibody described in all-glass paper and pre-service:
Described in described pre-service, all-glass paper for to soak described all-glass paper 1 hour in damping fluid;
Described damping fluid is prepared as follows: by every 2mlTritonX100,10g BSA, 50g sucrose and 950ml concentration, be that 0.02M, pH are that 7.4 PBS damping fluid is mixed to get damping fluid, adjust pH to 7.4, and constant volume be to 1000ml;
The time of described immersion is 1 hour, and the temperature of immersion is 37 ℃;
Described in described pre-service, superparamagnetism composite particle mark Enrofloxacin antibody is that described extension rate is 50 times by described superparamagnetism composite particle mark Enrofloxacin antibody dilution.Described dilution is damping fluid used in pre-service all-glass paper.
Described reacting pad is nitrocellulose filter.
After step I, before Step II, also comprise the step of the nitrocellulose filter that contains detection line and nature controlling line that sample pad that drying steps I obtains and step I obtain.
The application in residual Enrofloxacin in detecting sample of described test paper is also the scope of protection of the invention, and described sample is specially animal tissue's sample, animal urine, feed, honey or milk sample, and described sample is especially specially pig urine.
Know-why of the present invention:
It is relevant to the immuno-chromatographic assay technology of superparamagnetism composite particle mark that Enrofloxacin of the present invention detects reagent, to adopt the superparamagnetism composite particle material that serves as a mark, carry out class methods of fast immune chromatographic mensuration, this Technology Integration the research of the association areas such as magnetic Nano material chemosynthesis, labelling technique, flow measurement immunochromatography technique.
Why the present invention can detect Enrofloxacin, a kind of method that has been to adopt flow measurement immunochromatography based on superparamagnetism composite particle mark to detect, being about to Enrofloxacin antigen and dynamics is sprayed at respectively the p-wire (T line) and the nature controlling line (C line) that are positioned at the test section (being that NC film forms by nitrocellulose filter) in the middle of reaction plate and locates, in the sample pad of reaction plate lower end, spray the anti-Enrofloxacin antibody of superparamagnetism composite particle mark, reaction plate upper end is connected with adsorptive pads, and the formation of whole reaction plate as shown in Figure 1.Principle based on flow measurement immunochromatography, add after testing sample, the Enrofloxacin antigenic competition of the Enrofloxacin in sample and T line place spraying is combined magnetic mark Enrofloxacin antibody, at T line place, form Ag-Ab binary magnetic mark immune complex, unnecessary magnetic mark Enrofloxacin antibody is the magnetic mark immune complex with anti-mouse IgG formation at C line place.With magnetic test paper interpretoscope, measure the magnetic strength intensity of T line place superparamagnetism microballoon, by comparing and determine its positive or negative result with the threshold value of setting, C line measurement result is marked in the Quality Control as this assay method.
Its concrete technical step comprises:
(1) preparation of superparamagnetism composite particle label probe
Adopt applicable nanometer superparamagnetism composite particle, activate after its surperficial carboxyl, adopt the mode of chemical coupling that Enrofloxacin antibody orientation is connected to this superparamagnetism composite particle surface.
(2) test section T line and C line place antigen/antibody is coated
Adopt special spray film instrument, in the T of test section line place spraying Enrofloxacin antigen, in C line place spraying dynamics.
(3) sample pad place label probe is coated
Adopt special spraying instrument, in the anti-Enrofloxacin antibody of sample pad specific location spraying superparamagnetism microballoon mark.
(4) assembled formation of reaction plate
According to the structural drawing of reaction plate (seeing Fig. 1) requirement, in the middle of plastic support backboard, paste cellulose nitrate (NC) film as test section, in the T of NC film line end, paste sample pad, C line end is pasted adsorptive pads.Paste in the above transparent protective film.Adopt special test paper cutting machine, monoblock reaction plate is divided to the paper slip that is cut to certain broadband, with the special aluminium foil bag that drying agent is housed, pack.
(5) formation of Ag-Ab magnetic mark immune complex
Well place in the reaction plate of above-mentioned assembled formation adds testing sample, the Enrofloxacin antigenic competition of the Enrofloxacin in sample and T line place spraying is combined magnetic mark Enrofloxacin antibody, at T line place, form Ag-Ab binary magnetic mark immune complex, unnecessary magnetic mark Enrofloxacin antibody is the magnetic mark immune complex with anti-mouse IgG formation at C line place.
(6) magnetic mark immune complex magnetic field intensity detects
With magnetic test paper interpretoscope, measure the magnetic field intensity of T line place superparamagnetism microballoon, by comparing and determine its positive or negative result with the threshold value of setting, C line measurement result is marked in the Quality Control as this assay method.
The superparamagnetism composite particle that the present invention adopts is purchased from Shenzhen TELUS Science and Technology Ltd., catalog number is MP-2 (Fig. 2 is shown in by the water-solubility nanocrystalline TEM photo of poly hexadecanol ester (PMAH) modification), and the preparation method who adopts is by the oil-soluble Fe making with chemical method
3o
4be dissolved in and in organic reagent, obtain solution A, amphiphilic oligomer is dissolved in 3 distilled water and regulate pH be 8～10 solution B, under normal temperature, solution B is injected to solution A, mixed liquor fully stirs and makes organic solvent volatilization, carry out centrifuging, after the product of centrifuging is dried, get final product to obtain water miscible superparamagnetism composite particle.The saturated magnetic intensity of magnetic particle for preparing by this method is high, magnetic response fast, magnetic bead size uniform, monodispersity is good, stability is strong, it is fast to spring up the time, can meet well the testing requirement of LFIAs.
Described Ag-Ab magnetic mark immune complex, refer to add and detect after sample, through competition combination, the Enrofloxacin antigen-magnetic mark Enrofloxacin antibody mediated immunity compound forming at T line place, and the anti-mouse IgG bis-antiantibodys-magnetic mark Enrofloxacin antibody mediated immunity compound forming at C line place.
The magnetic field intensity of described magnetic mark immune complex, the quantity that refers to the combination magnetic bead under T line and C line place are detained respectively with the superparamagnetic resonance detector MAR of U.S. Quantum Dot, measure after resulting numerical value.By optimizing the condition of competitive reaction, research is found, the large quantitative determination separate sources of warp is as the normal sample of urine sample, blood and tissue sample extract etc., can determine the mensuration average of the normal sample in variant source, using that this determines that as critical value (cutoff) T line detects the positive or negative result of sample.C line measurement result is marked in the Quality Control as this assay method.
The chemical name of Enrofloxacin is 1-cyclopropyl-7-(4-ethyl-1-piperazinyl) fluoro-Isosorbide-5-Nitrae-dihydro of-6--4-oxo-3-quinoline carboxylic acid.
Of the present invention experimental results show that, by the research to superparamagnetism composite particle, Enrofloxacin antigen and Enrofloxacin antibody molecule characteristic, by the optimization to the preparation of multiple superparamagnetism composite particle, coated and finishing condition, select applicable superparamagnetism composite particle and specific antibody to carry out directed covalent chemical coupling, obtain functional magnetic mark probe, and by optimizing the various conditions of competitive immunization reaction, reach the objective detection to enrofloxacin residual medicine, realized the quick and Sensitive Determination to enrofloxacin residual medicine.Tool has the following advantages: highly sensitive, high specificity, quick, easy, can realize the mensuration that objectifies.
Accompanying drawing explanation
Fig. 1 is magnetic test paper structure schematic diagram
Fig. 2 is water-soluble superparamagnetism composite particle Electronic Speculum figure
Fig. 3 is Enrofloxacin magnetic detection paper value and concentration standard curve figure
Embodiment
The experimental technique using in following embodiment if no special instructions, is conventional method.
In following embodiment, material used, reagent etc., if no special instructions, all can obtain from commercial channels.
The preparation of embodiment 1, enrofloxacin residual thing magnetic mark quick detection test paper
(1) preparation of superparamagnetism composite particle mark Enrofloxacin antibody
Employing particle diameter is that 100nm, magnetic saturation intensity are 40emu/g, and corresponding external magnetic field response speed is that 20 seconds, surperficial carboxyl-content are superparamagnetism composite particle (the superparamagnetism Fe of 80 μ mol/g
3o
4nano particle) (purchased from Shenzhen TELUS Science and Technology Ltd., catalog number is MP-2) mark Enrofloxacin antibody.
Concrete grammar is:
1) get the MES damping fluid of 0.1M for the above-mentioned magnetic particle of 2.5mg (take 1.066g MES, 0.45g NaCl is dissolved in 50ml pure water, adjust pH to 4.7) wash and use after the magnet stand separation and concentration of 0.4T, by 1ml concentration, be that 0.1M, pH value are 4.7 MES damping fluid is resuspended, add 1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC) of 0.96mg (final concentration is 5mM) and 1.15mg (final concentration is 10mM) N-maloyl imines (NHS) in wherein.Temperature of reaction is 37 ℃, reacts after half an hour, obtains activating rear magnetic particle;
2) with the borate buffer solution washing of 50mM pH=8.5, get 0.15mg enrofloxacin monoclonal antibody (Sheng Dilong bio tech ltd, Beijing, ENX-088, Enrofloxacin antibody titer 10
6, Enrofloxacin antibody affinity costant is 10
8m
-1) and the above-mentioned magnetic particle borate buffer solution that is mixed into 0.8ml 50mM pH=8.5 (take 1.9gNa
2b
4o
7.10H
2o is dissolved in 100ml pure water, adjusts pH to 8.5) in fully mix.The lower reaction of room temperature (25 ℃) 3.5 hours, allows antibody and magnetic particle form stable peptide bond covalent bond, obtains containing the reactant liquor of magnetic particle after coupling;
3) after reaction finishes, to step 2) to add final concentration in the reactant liquor that obtains be the BSA (Sigma-aldrich of 5% (quality percentage composition), 85041C) residual activity amino sites is sealed, reaction is carried out 0.5 hour at 37 ℃, obtains the reactant liquor that contains the rear magnetic particle of sealing; After completing, with the 0.02M PBS damping fluid of pH=7.4, (take 2.3g Na
2hPO
4, 0.524g NaH
2pO
4.H
2o, 8.77g NaCL are dissolved in 1L pure water, adjust pH to 7.4) washing, resuspended rear 4 ℃ of preservations are stand-by, obtain superparamagnetism composite particle mark Enrofloxacin antibody.
(2) Enrofloxacin antigen is synthetic
Enrofloxacin haptens be Enrofloxacin (Beijing Heng Yuanqitian Chemical Engineering Technology research institute, 30235CDCT-C13170000).
Enrofloxacin is QNS, and molecule band carboxyl itself can be directly and albumen coupling.
Concrete steps are:
1) get 35.9mg Enrofloxacin, 3ml DMF (DMF) and 3ml dioxane (dioxane is originally as solution) and be mixed to get mixed liquor a, the temperature of mixing is 25 ℃, and the time of mixing is 30min, and the mode of mixing is concussion;
2) the mixed liquor a step 1 of 6ml) obtaining, 26.2 μ l (final concentration is 0.1mmol) the positive amine of tributyl stirs 15min at 4 ℃, obtain mixed liquor b, in mixed liquor b, add 1.5 μ l isobutyl chlorocarbonate (about 0.1mmol) stir-activating 1h at 25 ℃; The Enrofloxacin solution that obtains having activated;
3) 100mg BSA is dissolved in 10ml 0.1mol/L, obtains BSA BAS in the dobell's solution that pH is 8.5, preserves at 4 ℃ stand-by;
4) Enrofloxacin solution 6ml being activated slowly dropwise adds in 10mlBSA BAS by separating funnel under ice bath (4 ℃), and stirring reaction 12h, obtains mixed liquor c;
5) by gained mixed liquor c, in concentration, be 0.02mol/L, 4 ℃ of dialysis 48h in the PBS solution that pH is 7.4, every 6h changes a dislysate, removes unreacted little molecule.Products obtained therefrom freeze dryer freeze-drying, in-20 ℃ of preservations, obtains Enrofloxacin antigen.
(3) preparation of Enrofloxacin magnetic mark quick detection test paper
Adopt 0.02M PBS (pH=7.4) damping fluid, by sheep anti-mouse igg antibody (Bo You bio tech ltd, Changsha, ABGAM-0500) and the concentration of above-mentioned (two) Enrofloxacin antigen of obtaining be all formulated as concentration 1mg/ml, select the BioJet shower nozzle in the XYZ3050 spray film system of BioDot sheep anti-mouse igg antibody to be sprayed onto to control line (the Control Line of nitrocellulose filter (NC film), C line) position, the Enrofloxacin antigen that above-mentioned (two) are obtained is sprayed onto detection line (Test Line, T line) position, in relative humidity, be that dehumidifier dried for standby after 4 hours is carried out in drying plant below 10%.(described in every 1L, damping fluid is prepared as follows: by every 2mlTritonX100 with film, to process damping fluid, 10g BSA, 50g sucrose and 950ml concentration are 0.02M, pH is that 7.4 PBS damping fluid is mixed to get damping fluid, adjust pH to 7.4, and constant volume is to 1000ml) soak all-glass paper 1 hour, the temperature of soaking is 37 ℃, in same dehumidifier condition, carry out dehumidifier after 4 hours, with above-mentioned film, processing damping fluid presses after the Enrofloxacin antibody of 50 times of dilution paramagnetism composite particle marks, adopt AirJet shower nozzle in the XYZ3050 spray film system of BioDot this dilution magnetic labeling antibody to be sprayed into preparation on the glass fibre element film of above-mentioned processing and form sample pad, in same dehumidifier condition, be dried.In 100,000 grades of cleanings and dry workshop above-mentioned dried NC film, magnetic pad, thieving paper, backboard and diaphragm by arranging in pairs or groups shown in Fig. 1 after assembling; adopting the CM4000 cutting system of BioDot is the width of 5mm/ bar by the Paperboard cutting posting; pack into detect and use intermediate plate stand-by, obtain detecting the immune chromatography test paper of Enrofloxacin.
The result schematic diagram of this test paper as shown in Figure 1.
The detection of immune chromatography test paper sensitivity, cross reaction and the accuracy of embodiment 2, enrofloxacin residual thing.
1, the mensuration of sensitivity
Take appropriate Enrofloxacin (Beijing Heng Yuanqitian Chemical Engineering Technology research institute, catalog number: 30235CDCT-C13170000), dissolve the standard inventory solution that is formulated as 100ug/ml with 0.01M sodium hydroxide solution.With PBS (pH=7.4) dilution of 0.02M be formulated as 0,0.001,0.005,0.01,0.05,0.1,0.5,1,5, the standard solution of 10ug/L, add respectively in the immune chromatography test paper of the detection Enrofloxacin being obtained by embodiment 1, and adopt superparamagnetic resonance detector MAR (Magna BioSciences, 8094-101-01 & 8094-101-02) to read.Detecting step: first detected sample is recovered to room temperature (25 ℃) before detection, with accurate pipettor, get the application of sample end that detected sample 100 μ l vertically slowly splash into magnetic test strips, then splash into 50ul washing fluid (0.02M, pH 7.4, PBS), after 20 minutes, with MAR, test.
Its testing result is as shown in table 1 below.From testing result data, can find that detected value when detected value is with 0ug/L when Enrofloxacin concentration is 0.001ug/L has intersects, and when concentration is 0.005ug/L, detected value and 0ug/L value can distinguish completely, and concentration curve R
2=0.9888, better linear, illustrate that the detection sensitivity of test paper can reach 0.005ug/L.
Enrofloxacin magnetic detection paper value and concentration curve are as shown in Figure 3.
The magnetic detection paper value of table 1 Enrofloxacin variable concentrations sample
2, the mensuration of cross reaction
Select Ciprofloxacin (Beijing Heng Yuanqitian Chemical Engineering Technology research institute, 30233CDCT-C11668500), Danofloxacin (Sigma-aldrich, 33700-100MG-R), Norfloxacin (Beijing Heng Yuanqitian Chemical Engineering Technology research institute, 30234CDCT-C15648000), Enoxacin (Beijing Heng Yuanqitian Chemical Engineering Technology research institute, 29641NIC-130453), Ofloxacin (Beijing Heng Yuanqitian Chemical Engineering Technology research institute, 30237CDCT-C15717000) with Pei Nuosha star (Sigma-aldrich, 33899-100MG-R), be made into respectively series concentration, use the immune chromatography test paper by the detection Enrofloxacin of embodiment 1 to detect.Calculate the IC50 that respectively competes thing, with following formula, calculate respectively the cross reacting rate of these 5 kinds of medicines and CAP magnetic test paper.Computing formula is: cross reacting rate (%)=[IC50 (CAP)/IC50 (medicine to be measured)] * 100.
Mensuration and result of calculation are as shown in table 2.Result shows that Enrofloxacin magnetic test paper is complete intersection to Ciprofloxacin, and Danofloxacin is had to certain intersection, less to all the other several crossing-over rates.
The cross reaction of table 2 Enrofloxacin magnetic test paper and other medicines
3, the mensuration of accuracy and the recovery
3.1 urine samples:
The urine of clarification can be directly used in detection, if cloudy urine needs first centrifugal (4000g) 10min, gets supernatant and detects.
The assay method of 3.2 accuracys
Pig urine samples 60Fen You to be measured Animal &. Plant Inspection and Quarantine Techn Center, Shenzhen Bureau of Impor provides, and known wherein 55 parts of (being numbered 1-55) negative samples, 5 parts of (being numbered 56-60) positive samples.Use immune chromatography test paper and the U.S.'s ELISA of Beacon company kit of the detection Enrofloxacin being obtained by embodiment 1 to detect 60 duplicate samples simultaneously;
With magnetic test paper interpretoscope, measure the magnetic field intensity of T line place superparamagnetism microballoon, by comparing and determine its positive or negative result with the threshold value of setting, C line measurement result is marked in the Quality Control as this assay method.
Threshold value be less than 635 positive, threshold value be greater than 635 negative.
The mensuration of 3.3 accuracys
The testing result of the immune chromatography test paper of the detection Enrofloxacin being obtained by embodiment 1 is that to be numbered the sample of 1-55 negative, its threshold value is respectively 683.2, 661.5, 676.9, 684.8, 673.4, 695.3, 684.7, 688.6, 680.1, 671.3, 687.3, 689.7, 668.8, 673.2, 685.3, 683.7, 673.9, 694.2, 695.6, 697.1, 692.5, 677.4, 686.8, 684.3, 690.2, 699.8, 697.5, 680.8, 683.4, 685.7, 674.6, 691.3, 698.5, 694.3, 688.7, 680.4, 674.8, 664.3, 692.4, 681.2, 673.7, 686.9, 678.5, 696.9, 689.4, 697.6, 688.5, 687.2, 679.3, 698.8, 692.2, 685.7, 689.6, 685.5, 671.5.
The sample that is numbered 56-60 is positive, and its threshold value is respectively 541.3,365.5,247.8,142.9,58.7.
The testing result of the U.S. ELISA of Beacon company kit is consistent with above-mentioned detection paper result.
Illustrate that detection paper of the present invention is correct.
The assay method of 3.4 recovery
After 10 duplicate samples of the numbering 1-10 of above-mentioned detection feminine gender are mixed, Enrofloxacin (ENR) titer (0.01,0.1,0.5,1,5ug/L) of variable concentrations is added in preparation.Add each test of sample 5 times, and calculate recovery rate.
The mensuration of 3.5 recovery
Determination of recovery rates the results are shown in Table 3, and the recovery that Enrofloxacin adds in pig urine is 87%～106.4%, average recovery rate 95.08%, and the coefficient of variation 6.39%～9.37%, average coefficient of variation 7.98%, accuracy is better.
Table 3 determination of recovery rates
Claims (6)
1. detect an immune chromatography test paper for Enrofloxacin, comprise sample pad, the reacting pad that is connected in described sample pad one end that contains superparamagnetism composite particle mark Enrofloxacin antibody, the adsorptive pads that is connected in the described reacting pad other end; Described reacting pad is coated with detection line and the nature controlling line being separated from each other, and described detection line contains Enrofloxacin antigen, described nature controlling line contain can with the antiantibody of described Enrofloxacin antibody specific bond;
Described superparamagnetism composite particle mark Enrofloxacin antibody is the condensate that Enrofloxacin antibody and superparamagnetism composite particle form with peptide bond covalent bond;
Described Enrofloxacin antibody is enrofloxacin monoclonal antibody;
Described Enrofloxacin antigen is the conjugate of Enrofloxacin haptens and carrier protein; Described Enrofloxacin haptens is Enrofloxacin; Described carrier protein is BSA; The haptenic coupling ratio of described carrier protein and Enrofloxacin is 1:10;
The antiantibody of described and described Enrofloxacin antibody specific bond is sheep anti-mouse igg antibody; The concentration of described Enrofloxacin antigen and described sheep anti-mouse igg antibody is 1mg/ml;
Described superparamagnetism composite particle is Fe
3o
4nano particle;
The particle diameter of described superparamagnetism composite particle is 100nm;
The magnetic saturation intensity of described superparamagnetism composite particle is 40emu/g, and corresponding external magnetic field response speed is 20 seconds; The carboxyl-content on described superparamagnetism composite particle surface is 80 μ mol/g;
Described Enrofloxacin antibody affinity costant is 10
8m
-1;
Described reacting pad is nitrocellulose filter;
Described superparamagnetism composite particle mark Enrofloxacin antibody is prepared as follows:
1) by every 2.5mg superparamagnetism composite particle, 0.96mg1-ethyl-(3-dimethylaminopropyl) carbodiimide, 1.15mg N-maloyl imines and 1ml concentration, be that 2-(N-morpholine) the ethyl sulfonic acid damping fluid that 0.1M, pH value are 4.7 mixes, reaction, obtains activating rear magnetic particle; Temperature of reaction is 37 ℃, and the reaction time is 0.5h;
2) every 2.5mg step 1) being obtained activate rear magnetic particle, 0.15mg Enrofloxacin antibody and 0.8ml concentration is that 50mM pH is that 8.5 borate buffer solution mixes, reacts, and obtains containing the reactant liquor of magnetic particle after coupling; Temperature of reaction is 25 ℃, and the reaction time is 3.5h;
3) to step 2) add BSA to mix in the reactant liquor that obtains to obtain mixed liquor, reaction, obtain containing the reactant liquor of magnetic particle after sealing; Temperature of reaction is 37 ℃, and the reaction time is 0.5h;
The mass percentage concentration of described BSA in described mixed liquor is 5%;
Described Enrofloxacin antigen is prepared as follows:
A) get every 35.9mg Enrofloxacin, 3ml DMF and 3ml dioxane and be mixed to get mixed liquor a, described mixing temperature is 25 ℃, and described incorporation time is 30min, and the mode of described mixing is concussion;
B) by the steps A of every 6ml) the mixed liquor a that obtains and the positive amine of 26.2 μ l tributyls mixes, and obtains mixed liquor b, in mixed liquor b, adds 1.5 μ l isobutyl chlorocarbonates reactions; The Enrofloxacin solution that obtains having activated; The temperature of described mixing is 4 ℃, and the time of described mixing is 15min, and the temperature of described reaction is 25 ℃, and the time of described reaction is 1h;
C) get every 100mg carrier protein and be dissolved in 10ml concentration 0.1mol/L, in the dobell's solution that pH is 8.5, obtain carrier protein BAS;
D) by every 6ml step B) the good Enrofloxacin solution of activation that obtains adds 10ml step C) in the described carrier protein BAS that obtains, reaction, obtains mixed liquor c, dialysis, freeze-drying, obtain Enrofloxacin antigen; The temperature of described reaction is 4 ℃, and the reaction time is 12h;
In the preparation method of described superparamagnetism composite particle mark Enrofloxacin antibody:
After described step 3), also comprise magnetic particle after the sealing in the described reactant liquor that contains the rear magnetic particle of sealing is washed, suspended, obtain the step of superparamagnetism composite particle mark Enrofloxacin antibody, it is that 0.02M pH is 7.4 PBS damping fluid that described cleansing solution and suspending liquid are concentration.
2. a method of preparing the immune chromatography test paper that detects Enrofloxacin, comprises the steps:
I, prepare sample pad and contain detection line and the reacting pad of nature controlling line respectively;
The reacting pad that contains detection line and nature controlling line and adsorptive pads that II, the sample pad that step I is obtained, step I obtain paste on backboard successively, obtain detecting the immune chromatography test paper of Enrofloxacin;
The described reacting pad that contains detection line and nature controlling line is prepared as follows: the two ends zones of different that described and antiantibody Enrofloxacin antibody specific bond in test paper in the described Enrofloxacin antigen in test paper in claim 1 and claim 1 is sprayed on respectively to reacting pad, form detection line and nature controlling line, obtain the reacting pad that contains detection line and nature controlling line;
Described sample pad is prepared as follows: the described superparamagnetism composite particle mark Enrofloxacin antibody in test paper in claim 1 is sprayed onto on all-glass paper, obtains sample pad.
3. method according to claim 2, is characterized in that:
In described sample pad preparation method: go forward described superparamagnetism composite particle mark Enrofloxacin antibody is sprayed onto to described all-glass paper, also comprise described in pre-service the step of superparamagnetism composite particle mark Enrofloxacin antibody described in all-glass paper and pre-service:
Described in described pre-service, all-glass paper for to soak described all-glass paper 1 hour in damping fluid;
Described damping fluid is prepared as follows: by every 2mlTritonX100,10g BSA, 50g sucrose and 950ml concentration, be that 0.02M, pH are that 7.4 PBS damping fluid is mixed to get damping fluid, adjust pH to 7.4, and constant volume be to 1000ml;
The time of described immersion is 1 hour, and the temperature of immersion is 37 ℃;
Described in described pre-service, superparamagnetism composite particle mark Enrofloxacin antibody is that described extension rate is 50 times by described superparamagnetism composite particle mark Enrofloxacin antibody dilution;
Described reacting pad is nitrocellulose filter.
4. method according to claim 3, is characterized in that:
After step I, before step II, also comprise the step of the nitrocellulose filter that contains detection line and nature controlling line that sample pad that drying steps I obtains and step I obtain.
5. test paper application in residual Enrofloxacin in detecting sample described in claim 1, described sample is animal tissue's sample, animal urine, feed, honey or milk sample.
6. application according to claim 5, is characterized in that: described sample is pig urine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110157590.5A CN102269765B (en) | 2011-06-13 | 2011-06-13 | Immunochromatographic test paper for detecting enrofloxacin and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110157590.5A CN102269765B (en) | 2011-06-13 | 2011-06-13 | Immunochromatographic test paper for detecting enrofloxacin and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102269765A CN102269765A (en) | 2011-12-07 |
| CN102269765B true CN102269765B (en) | 2014-03-19 |
Family
ID=45052126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110157590.5A Expired - Fee Related CN102269765B (en) | 2011-06-13 | 2011-06-13 | Immunochromatographic test paper for detecting enrofloxacin and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102269765B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103091495B (en) * | 2013-01-16 | 2014-11-05 | 河南知微生物工程有限公司 | Test paper card for quickly detecting residues of fluoroquinolones and preparation method of test paper card |
| CN113238037B (en) * | 2021-04-29 | 2023-09-26 | 浙江工业大学 | Detection system and detection method for detecting pick-level enrofloxacin |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007063180A (en) * | 2005-08-31 | 2007-03-15 | Frontier Kenkyusho:Kk | Method of detecting new quinolone antibacterial agent |
| WO2009075376A1 (en) * | 2007-12-13 | 2009-06-18 | Sekisui Medical Co., Ltd. | Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| CN101498726A (en) * | 2008-01-30 | 2009-08-05 | 北京望尔生物技术有限公司 | Colloidal gold test paper card for detecting enrofloxacin medicament residue |
| JP2011017697A (en) * | 2009-06-12 | 2011-01-27 | Sekisui Medical Co Ltd | Anti-ofloxacin monoclonal antibody and immunological measuring method of ofloxacin using the same |
-
2011
- 2011-06-13 CN CN201110157590.5A patent/CN102269765B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007063180A (en) * | 2005-08-31 | 2007-03-15 | Frontier Kenkyusho:Kk | Method of detecting new quinolone antibacterial agent |
| WO2009075376A1 (en) * | 2007-12-13 | 2009-06-18 | Sekisui Medical Co., Ltd. | Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| CN101498726A (en) * | 2008-01-30 | 2009-08-05 | 北京望尔生物技术有限公司 | Colloidal gold test paper card for detecting enrofloxacin medicament residue |
| JP2011017697A (en) * | 2009-06-12 | 2011-01-27 | Sekisui Medical Co Ltd | Anti-ofloxacin monoclonal antibody and immunological measuring method of ofloxacin using the same |
Non-Patent Citations (2)
| Title |
|---|
| 羧基功能化超顺磁性复合粒子的制备及其在免疫层析中的应用研究;袁航;《中国博士学位论文数据库医药卫生科技辑》;20100815(第08期);第47、53-54、64-66、68、109页 * |
| 袁航.羧基功能化超顺磁性复合粒子的制备及其在免疫层析中的应用研究.《中国博士学位论文数据库医药卫生科技辑》.2010,(第08期), |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102269765A (en) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102353775B (en) | Immunochromatographic test strip for detecting malachite green (MG) and preparation process thereof | |
| CN102253211B (en) | Immune chromatography test paper for detecting clenbuterol hydrochloride and preparation method thereof | |
| CN102323415B (en) | Immunochromatography test paper for detecting Ciprofloxacin and preparation method thereof | |
| JPH07506195A (en) | Immobilization of specific binding assay reagents | |
| CN102288765B (en) | Immunofluorescence chloramphenicol detecting method based on quantum dots and special kit | |
| CN102353774A (en) | Immunochromatographic test paper for detecting chloramphenicol and its preparation method | |
| CN107991487A (en) | A kind of fluorescent microsphere immune test paper card, preparation and detection method for detecting carbostyril antibiotic | |
| CN103575889B (en) | A kind of test strips and method detecting vancomycin | |
| CN102288764B (en) | Immunofluorescence method and special kit for detecting melamine based on quantum dots | |
| CN103558381A (en) | Immunochromatographic test paper for detecting human immunodeficiency virus antibodies and preparation method thereof | |
| CN109374907B (en) | Colistin colloidal gold detection kit and application thereof | |
| CN102230936B (en) | Immunochromatography test paper for detecting ractopamine and preparation method thereof | |
| CN102353773B (en) | Immune chromatographic test paper for detecting melamine and preparation method thereof | |
| CN102269765B (en) | Immunochromatographic test paper for detecting enrofloxacin and preparation method thereof | |
| CN102253214B (en) | Quantum dot-based method for detecting ciprofloxacin by immunofluorescence and special kit | |
| CN105334323A (en) | Method and test strip for detecting zilpaterol, and application of test strip | |
| CN102539412A (en) | Magnetic particle chemical luminous kit for detecting clenbuterol and application thereof | |
| CN102253224B (en) | Immunochromatographic test paper for detecting diethylstilbestrol and preparation method thereof | |
| CN103558399A (en) | Immunochromatographic test paper for detecting hepatitis B surface antigens and preparation method thereof | |
| CN102262157B (en) | Quantum dot-based method for immunofluorescence of clenbuterol hydrochloride and special kit thereby | |
| CN102353785B (en) | Immunofluorescence detection method for detection of enrofloxacin based on quantum dots and special kit thereof | |
| CN102183641B (en) | Ractopamine immunochromatographic assay test paper strip | |
| CN103073635B (en) | Salbutamol artificial antigen synthesis method and application thereof to colloid gold immunity test strip | |
| CN104345145A (en) | Test strip for detecting vomitoxin and applications thereof | |
| CN103420879B (en) | Dapsone hapten and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140319 Termination date: 20200613 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |